Matches in Nanopublications for { ?s ?p "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP899334.RAccMcn7T4m5fDh2CGZsD83BVXNgEnGqoicOhrbf0rfKw130_assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899334.RAccMcn7T4m5fDh2CGZsD83BVXNgEnGqoicOhrbf0rfKw130_provenance.
- NP899335.RAALb84OOv-6wCTZ3l4FguDLTeztQxwsQXCEhxoh2DRpc130_assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899335.RAALb84OOv-6wCTZ3l4FguDLTeztQxwsQXCEhxoh2DRpc130_provenance.
- NP378672.RAJiqbQCrVJyFyLiRahb0ONVkwyqrD1sD7uZ_qFTFC8YM130_assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378672.RAJiqbQCrVJyFyLiRahb0ONVkwyqrD1sD7uZ_qFTFC8YM130_provenance.
- NP380028.RAOXApAyvJDg7ZaR5p6hI1DkkU76JWN5bDZYj-FjaZB5k130_assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380028.RAOXApAyvJDg7ZaR5p6hI1DkkU76JWN5bDZYj-FjaZB5k130_provenance.
- NP899336.RA6XwaHmnL94L7XyrY3T2uQcXADg3DZO6rgGE8rdMpKYA130_assertion description "[Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899336.RA6XwaHmnL94L7XyrY3T2uQcXADg3DZO6rgGE8rdMpKYA130_provenance.